GLP-1/GlP agonists

John316

New_Member
Joined
Oct 3, 2024
Messages
26
Reaction score
21
Location
US-NC
The following was posted by FLEXNP on bluesky social along with these pics.

“Things that make me go 🧐🧐 Long acting GIP agonist given to humans for 12 weeks resulted in a significant increase in insulin sensitivity (~33%) vs GLP-1 agonist. Combine the two and the effect mirrors GIP alone. Makes one wonder why there aren't more dual GLP 1/GIP agonists in development!”
 

Attachments

  • 32a6fb83-88a4-476d-a18a-11607bdeaac9.jpg
    32a6fb83-88a4-476d-a18a-11607bdeaac9.jpg
    198.8 KB · Views: 84
  • ca7e9241-d36d-4f3c-87d8-01a9406ad870.jpg
    ca7e9241-d36d-4f3c-87d8-01a9406ad870.jpg
    328.2 KB · Views: 81
The following was posted by FLEXNP on bluesky social along with these pics.

“Things that make me go 🧐🧐 Long acting GIP agonist given to humans for 12 weeks resulted in a significant increase in insulin sensitivity (~33%) vs GLP-1 agonist. Combine the two and the effect mirrors GIP alone. Makes one wonder why there aren't more dual GLP 1/GIP agonists in development!”
How may dual GIP and GLP-1 agonists ("twincretins") do you want? We already have tirezpatide. The slides mentioned a few I hadn't heard of. Retatrutide and pemvidutide are also twincretins.
 
is lily making another one? why when they already have tirezaptide and retatrutide?
 

Trending content

Latest posts

Forum statistics

Threads
2,655
Messages
46,592
Members
4,946
Latest member
lynnlewis
Back
Top